Condition: Coccyx Disorder · Neuropathic Pain · Coccygodynia · Sponsor: Nantes University Hospital
The primary objective is to demonstrate the analgesic effect at day 60 of 8% capsaicin patch (Qutenza) for the treatment of patients with coccygodyinia.
This description comes directly from the study's public registry record.
Amélie LEVESQUE, MD · +33240083912 · amelie.levesque@chu-nantes.fr
Always discuss trial participation with your own doctor first.
| Brest University Hospital | Brest, France | Recruiting |
| Vendée Departmental Hospital | La Roche-sur-Yon, France | Recruiting |
| Confluent Private Hospital Centre | Nantes, France | Recruiting |
| Nantes University Hospital | Nantes, France | Recruiting |
| GH Paris saint Joseph | Paris, France | Recruiting |
| Rouen University Hospital | Rouen, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06023706